3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Breast
1
Conditions
Breast Neoplasms
44
Neoplasms
43
Lung Neoplasms
28
Colorectal Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
15
Ovarian Neoplasms
15
Pancreatic Neoplasms
13
Melanoma
11
Uterine Cervical Neoplasms
10
Neoplastic Cells, Circulating
9
Neoplasm Metastasis
9
Sarcoma
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Glioma
8
Glioblastoma
8
Hematologic Neoplasms
7
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Lymphoma
6
Leukemia, Myeloid, Acute
6
Endometrial Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Gastrointestinal Neoplasms
5
Disease
5
Brain Neoplasms
5
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Peritoneal Neoplasms
4
Interventions
Cyclophosphamide
21
Cyclosporine
14
fludarabine phosphate
13
Whole-Body Irradiation
13
Peripheral Blood Stem Cell Transplantation
13
Filgrastim
10
Rituximab
9
Mycophenolic Acid
9
Antilymphocyte Serum
9
Radiotherapy
7
Methotrexate
7
Busulfan
7
Melphalan
6
Psychiatric Rehabilitation
5
Etoposide
5
Dexamethasone
5
Cytarabine
5
Aprepitant
5
fludarabine
4
Vincristine
4
Ondansetron
4
Methylprednisolone
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Cord Blood Stem Cell Transplantation
4
plerixafor
3
Zidovudine
3
Therapeutics
3
Stem Cell Transplantation
3
Prednisone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, Non-Hodgkin
×
Blood Specimen Collection
×
Clear all
NCT05595577
2026-03-20
PALS
Wake Forest University Health Sciences
Phase NA
Recruiting
110 enrolled
NCT05422521
2024-01-30
CART-Omic
Centre Hospitalier Universitaire de Nice
Phase NA
Unknown
20 enrolled